These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19293040)

  • 1. Increased connective tissue growth factor expression in a rat model of chronic heart allograft rejection.
    Yuan YC; Xia ZK; Mu JJ; Zhang QC; Yin BL
    J Formos Med Assoc; 2009 Mar; 108(3):240-6. PubMed ID: 19293040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of connective tissue growth factor in acute heart allograft rejection in rats.
    Yuan YC; Xia ZK; Zhang QC; Yin BL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):425-31. PubMed ID: 18544847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Connective tissue growth factor and pulmonary allograft fibrosis in rats].
    Yuan YC; Wang DJ; Yin BL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):873-6. PubMed ID: 18007087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury.
    Shi Y; Tu Z; Bao J; Sun H; Wang W; Luo G; Li S; Li Y; Bu H
    Scand J Urol Nephrol; 2009; 43(5):390-9. PubMed ID: 19921985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue growth factor (CTGF/CCN2): a protagonist in cardiac allograft vasculopathy development?
    Pantou MP; Manginas A; Alivizatos PA; Degiannis D
    J Heart Lung Transplant; 2012 Aug; 31(8):881-7. PubMed ID: 22503846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
    Tuuminen R; Nykänen A; Keränen MA; Krebs R; Alitalo K; Koskinen PK; Lemström KB
    Transplant Proc; 2006 Dec; 38(10):3271-3. PubMed ID: 17175246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experimental study of cardiac allograft vasculopathy and myocardial fibrosis in rats.
    Song G; Zhang J; Jiang D; Wang X; Xu J
    Transplant Proc; 2008 Oct; 40(8):2712-5. PubMed ID: 18929843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Monocyte Chemotactic Protein-1 and Nuclear Factor of Kappa B Pathway in Rejection of Cardiac Allograft in Rat.
    Bai X; Qi Z; Song G; Zhao X; Zhao H; Meng X; Liu C; Bing W; Bi Y
    Transplant Proc; 2015; 47(6):2010-6. PubMed ID: 26293090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of connective tissue growth factor in a rat model of chronic allograft nephropathy.
    Tu Z; Shi Y; Wang J; Bao J; Bu H
    Nephrology (Carlton); 2007 Apr; 12(2):166-71. PubMed ID: 17371341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of platelet-derived growth factor in rat cardiac allograft vasculopathy and fibrosis.
    Song G; Fang Y; Wang X; Wu S; Song H
    Transplant Proc; 2008 Oct; 40(8):2716-9. PubMed ID: 18929844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cadherin expression in cardiac allograft vasculopathy: bench to bedside translational investigation.
    Collot-Teixeira S; McGregor JL; Morser K; Chalabreysse L; McDermott-Roe C; Cerutti C; Guzman A; Michel JB; Boissonnat P; Sebbag L; Thivolet-Bejui F; Bricca G; Obadia JF; Roussoulières A
    J Heart Lung Transplant; 2010 Jul; 29(7):792-9. PubMed ID: 20456977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.
    Zhao H; Zhang Y; Song G; Zhao W; Bai X; Zhang J; Zhao X
    Transplant Proc; 2013 Mar; 45(2):635-8. PubMed ID: 23498802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte-targeted HIF-1alpha gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat.
    Keränen MA; Nykänen AI; Krebs R; Pajusola K; Tuuminen R; Alitalo K; Lemström KB
    J Heart Lung Transplant; 2010 Sep; 29(9):1058-66. PubMed ID: 20580263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection.
    Wu GD; Tuan TL; Bowdish ME; Jin YS; Starnes VA; Cramer DV; Barr ML
    Transplantation; 2003 Aug; 76(3):609-14. PubMed ID: 12923453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
    Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
    Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.